Deficiency of acyl-CoA: dihydroxyacetone phosphate acyltransferase in patients with Zellweger (cerebro-hepato-renal) syndrome.
We have recently reported on plasmalogen deficiency in tissues and fibroblasts from patients with Zellweger syndrome. In this paper we have analyzed the activity of the first enzyme in the pathway leading to plasmalogen biosynthesis, i.e. acyl-CoA:dihydroxyacetone phosphate acyltransferase in liver, brain and cultured skin fibroblasts from Zellweger patients and controls. The results indicate a severe deficiency of this enzyme in Zellweger patients. Thus, the Zellweger syndrome constitutes the first inborn error of metabolism with a deficiency in an enzyme involved in phospholipid biosynthesis. Cultured amniotic fluid cells contained an enzymatic activity comparable to that of control fibroblasts. These findings suggest a method for prenatal diagnosis of this disease.
D000217:Acyltransferases / Q000172:deficiency*; D000653:Amniotic Fluid / Q000166:cytology; D001921:Brain / Q000201:enzymology; D002478:Cells, Cultured; D005347:Fibroblasts / Q000201:enzymology; D006579:Heterozygote; D006801:Humans; D007674:Kidney Diseases / Q000201:enzymology*; D008099:Liver / Q000201:enzymology; D008107:Liver Diseases / Q000201:enzymology*; D012886:Skull / Q000002:abnormalities*; D013577:Syndrome
D000217:Acyltransferases; C020051:glycerone-phosphate O-acyltransferase